期刊文献+

动物核酸疫苗研究进展 被引量:3

Progress on Nucleic Acid Vaccine in Animal
下载PDF
导出
摘要 核酸疫苗又称为基因疫苗、DNA疫苗,是20世纪90年代初从基因治疗研究领域发展起来的一种全新疫苗,具有能够激发机体体液和细胞免疫反应、不散毒、便于储存和运输等优点,是近年来研究的一个热点。抗原编码基因的选择、质粒的构建(包括启动子和增强子以及内含子的选择)、各种佐剂的应用以及疫苗接种方法和途径等因素可以提高和改变DNA疫苗的免疫效果与反应类型,已经有很多研究试图通过改变这些因素来提高DNA疫苗的免疫效果,为研制出高效实用的DNA疫苗提供了许多新思路。重要动物传染病包括流感、鸡新城疫、口蹄疫等的核酸疫苗得到了较深入研究,为其他疾病核酸疫苗的研究提供了有价值的参考。 Nucleic acid vaccine, also called gene vaccine or DNA vaccine, is a newly-developed vaccine, which derived from gene therapy in the early 1990s. From then on it absorbs researchers' attention because of so many advantages, including its ability to induce both cellular and humoral immune responses, no way to spread virus and easy to deposit and transportation. Researchers have designed various strategies to enhance the DNA vaccine potency, including the selection of different DNA encoding-Ag, constructing different plasmid vectors (including selecting different promoter, enhancer and intron) , using various adjuvants and different delivery strategies, which provide useful method to produce efficient and practical DNA vaccine. Some main animal infectious diseases, such as influenza, Newcastle disease and foot-and-mouth disease, had been studied deeply, which provide worthy candidate to study other diseases.
出处 《动物医学进展》 CSCD 2005年第9期34-36,共3页 Progress In Veterinary Medicine
关键词 核酸疫苗 佐剂 nucleic acid vaccine adjuvant
  • 相关文献

参考文献19

  • 1张以芳.核酸疫苗的构成及主要特点[J].上海畜牧兽医通讯,2000(2):11-11. 被引量:13
  • 2陈吉祥,薛飞群,李广林,赵荣材,于康震,陈化兰,陈洪岩,刘胜旺.CTAB脂质体介导鸡新城疫病毒核酸免疫研究[J].动物医学进展,2001,22(1):41-43. 被引量:15
  • 3方维焕,梁雪芽,李建荣.减毒沙门氏菌为载体传递DNA疫苗诱导对新城疫病毒的免疫保护[J].中国兽医学报,2003,23(6):527-530. 被引量:9
  • 4Cohen J. Naked DNA points way to vaccines[J]. Science, 1993,259:1691-1692.
  • 5Zijl M, Wensvoort G, Kluyver W, et al. Live attenuated pseudorabies virus expressing envelope glycoprotin E1 of hog cholera virus protects swine against both pseudorabies and hot cholera[J]. J Virol, 1991, 65:2761-2765.
  • 6Suarez D L,Cherry S.The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model[J].Avian Dis,2000,44(4):861-868.
  • 7Garg S, Oran A E, Hon H, et al.The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines[J].J Immunol,2004 ,173(1):550-558.
  • 8Van Rooij E M A, Glansbeek H L, Hilgers L A T, et al.Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant[J].J Virol,2002,76(20): 10540-10545.
  • 9Arrington J, Braun R P, Dong L, et al.Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines[J].J Virol,2002 ,76(9): 4536-4546.
  • 10Klinman D M, Yi A K, Beaucage S L, et al. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon[J].Immunology,1996,93( 7): 2879-2883.

二级参考文献39

  • 1Darji A,Guzman C A,Gerstel B,et al. Oral somatic transgene vaccination using attenuated Salmonella typhimurium[J]. Cell,1997,91 (6) :765-775.
  • 2Paglia P, Medina E, Arioli I, et al. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium,results in protective immunity against a murine fibrosarcoma[J]. Blood, 1998,92 (9) : 3 172-3 176.
  • 3Shata M T,Reitz M S Jr,DeVico A L,et al. Mucosal and systemic HIV- I Env-specific CD8 (+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vcctor[J]. Vaccine ,2001,20 (3-4) :623-629.
  • 4Gent schev I, Dietrich G, Spreng S ,et al. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes[J]. J Biotechnol, 2000,83(1): 19-26.
  • 5Peeters B P,de Leeuw O S,Koch G. Rescue of Newcastle disease virus from cloned cDNA:evidence that cleavability of the fusion protein is a major determinant for virulence[J]. J Virol,1999,73(6):5 001-5 009.
  • 6Gentsehev I ,Dietrich G ,Spreng S,et al. Recombinant attenuated bacteria for the delivery of subunit vaccines[J]. Vaccine, 2001, 19(17):2 621-2 628.
  • 7Melissa D D,Timothy T,Harry K,et al. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers [J]. Vaccine,1999,18(5-6) :449-459.
  • 8Darji A, zur Lage S,Garbe A I,et al. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier[J]. FEMS Immunol Med Microbiol,2000,27(4) :341-349.
  • 9Jain V, Mekalanos J J. Use of lambda phage S and R gene products in an inducible lysis system for vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems [J ]. Infect Immunol, 2000,68 (2) : 986- 989.
  • 10Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H,Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N. Characterization of an avian influenza A(H5N1) virus isolated from a child with a fatal respiratory illness. S

共引文献43

同被引文献77

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部